
1. Ann Oncol. 2021 Dec;32(12):1608-1617. doi: 10.1016/j.annonc.2021.09.004. Epub
2021 Oct 22.

The TeloDIAG: how telomeric parameters can help in glioma rapid diagnosis and
liquid biopsy approaches.

Billard P(1), Guerriau C(2), Carpentier C(3), Juillard F(4), Grandin N(5),
Lomonte P(4), Kantapareddy P(6), Dufay N(6), Barritault M(2), Rimokh R(7),
Verrelle P(5), Maucort-Boulch D(8), Figarella-Branger D(9), Ducray F(10), Dehais 
C(11), Charbonneau M(5), Meyronet D(12), Poncet DA(13); POLA network.

Author information: 
(1)Institut de Pathologie Est, Hospices Civils de Lyon, Lyon, France; Univ Lyon, 
Université Claude Bernard Lyon 1, CNRS UMR 5310, INSERM U 1217, Institut
NeuroMyoGène (INMG), Neuron-Muscle Interaction Team, Lyon, France.
(2)Institut de Pathologie Est, Hospices Civils de Lyon, Lyon, France.
(3)Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Inserm U 1127, CNRS UMR
7225, ICM, Paris, France.
(4)Univ Lyon, Université Claude Bernard Lyon 1, CNRS UMR 5310, INSERM U 1217,
LabEx DEVweCAN, Institut NeuroMyoGène (INMG), Team Chromatin Dynamics, Nuclear
Domains, Virus, Lyon, France.
(5)GReD Institute, CNRS UMR6293, INSERM U1103, University Clermont Auvergne,
Faculty of Medicine, Clermont-Ferrand, France.
(6)Hospices Civils de Lyon, Lyon, France.
(7)Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre
Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
(8)Biostatistics and Bioinformatics Department of the Hospices Civils de Lyon,
Lyon, France.
(9)Aix-Marseille Univ, CNRS, INP, Inst. Neurophysiopathol, Marseille, France;
AP-HM, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, Centre 
de Ressources Biologiques CRB-TBM, Marseille, France.
(10)Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre
Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon, France; Hospices 
Civils de Lyon, Hôpital Neurologique, Bron, France.
(11)Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau et de la
Moelle épinière, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière-Charles
Foix, Service de Neurologie 2-Mazarin, Paris, France.
(12)Institut de Pathologie Est, Hospices Civils de Lyon, Lyon, France; Univ Lyon,
Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard,
Centre de Recherche en Cancérologie de Lyon, Lyon, France.
(13)Institut de Pathologie Est, Hospices Civils de Lyon, Lyon, France; Univ Lyon,
Université Claude Bernard Lyon 1, CNRS UMR 5310, INSERM U 1217, Institut
NeuroMyoGène (INMG), Neuron-Muscle Interaction Team, Lyon, France. Electronic
address: delphine.poncet@chu-lyon.fr.

Comment in
    Ann Oncol. 2021 Dec;32(12):1472-1474.

BACKGROUND: In glioma, TERT promoter mutation and loss of ATRX (ATRX loss) are
associated with reactivation of telomerase or alternative lengthening of
telomeres (ALT), respectively, i.e. the two telomere maintenance mechanisms
(TMM). Strangely, 25% of gliomas have been reported to display neither or both of
these alterations.
MATERIALS AND METHODS: The C-circle (CC) assay was adapted to tumor
(formalin-fixed paraffin-embedded and frozen) and blood samples to investigate
the TMM.
RESULTS: We constructed a CC-based algorithm able to identify the TMM and
reported a sensitivity of 100% and a specificity of 97.3% (n = 284 gliomas). By
combining the TMM, the mutational status of the isocitrate dehydrogenase 1/2
(IDH) gene (IDHmt), and the histological grading, we propose a new classification
tool: TeloDIAG. This classification defined five subtypes: tOD, tLGA, tGBM_IDHmt,
tGBM, and tAIV, corresponding to oligodendroglioma, IDHmt low-grade astrocytoma, 
IDHmt glioblastoma, and IDHwt glioblastoma (GBM), respectively; the last class
gathers ALT+ IDHwt gliomas that tend to be related to longer survival (21.2
months) than tGBM (16.5 months). The TeloDIAG was 99% concordant with the World
Health Organization classification (n = 312), and further modified the
classification of 55 of 144 (38%) gliomas with atypical molecular
characteristics. As an example, 14 of 69 (20%) of TERTwt, ATRXwt, and IDHwt GBM
were actually tAIV. Outstandingly, CC in blood sampled from IDHmt astrocytoma
patients was detected with a sensitivity of 56% and a specificity of 97% (n = 206
gliomas and 30 healthy donors).
CONCLUSION: The TeloDIAG is a new, simple, and effective tool helping in glioma
diagnosis and a promising option for liquid biopsy.

Copyright © 2021 European Society for Medical Oncology. Published by Elsevier
Ltd. All rights reserved.

DOI: 10.1016/j.annonc.2021.09.004 
PMID: 34690007  [Indexed for MEDLINE]

Conflict of interest statement: Disclosure The authors have declared no conflicts
of interest.

